2005
DOI: 10.1038/nature03404
|View full text |Cite
|
Sign up to set email alerts
|

CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair

Abstract: Inherited mutations in BRCA2 are associated with a predisposition to early-onset breast cancers. The underlying basis of tumorigenesis is thought to be linked to defects in DNA double-strand break repair by homologous recombination. Here we show that the carboxy-terminal region of BRCA2, which interacts directly with the essential recombination protein RAD51, contains a site (serine 3291; S3291) that is phosphorylated by cyclin-dependent kinases. Phosphorylation of S3291 is low in S phase when recombination is… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

12
453
1
7

Year Published

2006
2006
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 418 publications
(474 citation statements)
references
References 46 publications
12
453
1
7
Order By: Relevance
“…As HR does not act in G1, and NHEJ has been proposed to act throughout the cell cycle (Saintigny et al, 2001;Rothkamm et al, 2003;Saleh-Gohari and Helleday, 2004;Esashi et al, 2005), the simplest explanation was that the HR over-stimulation reflected the defect in NHEJ in S and G2 phases. Surprisingly, we show here that, (1) an NHEJ defect in G1, but not in G2, stimulated IR-induced HR; (2) the cell cycle restriction for HR, that is in S/G2 phase, was not affected by the NHEJ defect; (3) the absence of delay at the G1/S transition was essential for the overstimulation of IR-induced HR in XRCC4 À cells; this allowed the presence in S/G2 of unrepaired DSB generated in G1.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…As HR does not act in G1, and NHEJ has been proposed to act throughout the cell cycle (Saintigny et al, 2001;Rothkamm et al, 2003;Saleh-Gohari and Helleday, 2004;Esashi et al, 2005), the simplest explanation was that the HR over-stimulation reflected the defect in NHEJ in S and G2 phases. Surprisingly, we show here that, (1) an NHEJ defect in G1, but not in G2, stimulated IR-induced HR; (2) the cell cycle restriction for HR, that is in S/G2 phase, was not affected by the NHEJ defect; (3) the absence of delay at the G1/S transition was essential for the overstimulation of IR-induced HR in XRCC4 À cells; this allowed the presence in S/G2 of unrepaired DSB generated in G1.…”
Section: Discussionmentioning
confidence: 99%
“…HR appears to be active from mid-S to G2 as attested by the fact that: (i) HR-defective vertebrate cells are more sensitive when irradiated in the late S/G2 phase (Cheong et al, 1994;Takata et al, 1998;Rothkamm et al, 2003;Hinz et al, 2005); (ii) Rad51 foci do not occur in G1 (Yuan et al, 2003;Aten et al, 2004); (iii) phosphorylation by cyclin-dependent kinase of BRCA2, an essential factor for Rad51 foci assembly, consistently disrupts BRCA2-Rad51 interaction only in G1 phase (Esashi et al, 2005); (iv) conservative HR has been proposed to occur preferentially in S phase (SalehGohari and Helleday, 2004). However, one study challenged such interpretations as it found Rad51 foci in G1 (Kim et al, 2005).…”
Section: Introductionmentioning
confidence: 99%
“…Our current knowledge of the Rad51 loading mechanism in multicellular organisms suggests that it is mediated by a complex set of protein-protein and protein-DNA interactions, orchestrated by Atm and Atr signaling and perhaps by more diverse cell signaling pathways [147]. By analogy with yeast, there may also be negative regulators, operating to inhibit Rad51 loading or disassemble Rad51 nucleoprotein filaments and suppress inappropriate recombination events [148].…”
Section: Molecular Functions Of Brca1 and Brca2mentioning
confidence: 99%
“…Phosphorylation of S3291 is low in S phase when recombination is active, but increases as cells progress toward mitosis. Phosphorylation of this residue impedes the interactions between Rad51 and the carboxyterminal domain of hBRCA2 (Esashi et al, 2005).…”
Section: Introductionmentioning
confidence: 99%